Open access · OA
via Europe PMC
Chronic periodontitis and systemic inflammation in the elderly: implications for neurodegeneration.
Kwon HJ, Ahn JH, Won MH, Kim DW.
Journal of neuroinflammation · 2026 · ▲ 1 citations
Abstract
Chronic periodontitis is increasingly recognized as a potential upstream contributor to neurodegenerative processes through sustained systemic inflammation, microbial dysbiosis, and blood-brain barrier (BBB) alterations. This review synthesizes human and experimental evidence linking periodontal pathogens-including but not limited to Porphyromonas gingivalis as well as broader dysbiotic consortia such as Tannerella forsythia, Treponema denticola, and other keystone oral taxa-to neuroinflammatory cascades associated with cognitive decline. Mechanistic insights highlight the roles of glial activation, proinflammatory cytokines, and polymicrobial virulence-mediated neuronal stress in bridging oral and brain pathology, while age-related factors such as immunosenescence and microbiome imbalance amplify systemic vulnerability. Human biomarker and imaging studies support an association between chronic periodontal inflammation and neurovascular dysfunction, suggesting that oral disease may act as a persistent peripheral amplifier of central immune activation. Recent research has expanded into biomarker discovery and translational implementation, yet progress remains limited by population heterogeneity, methodological variability, and regulatory complexity. Promising interventions-including anti-inflammatory therapies, oral hygiene optimization, probiotic or dietary modulation, and molecular strategies such as polymicrobial-targeted approaches, gingipain inhibition, and microRNA-based modulation-are discussed within emerging multi-omics and precision-medicine frameworks. Although standardization and longitudinal validation are still required, integrative approaches combining inflammatory, microbial, and genetic profiling may enable individualized risk assessment and targeted prevention. As global populations age, addressing the oral-brain axis offers a practical and modifiable pathway to lessen the burden of neurodegenerative diseases and support healthier cognitive aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1186/s12974-025-03664-4
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
HJ, K., JH, A., MH, W., & DW., K. (2026). Chronic periodontitis and systemic inflammation in the elderly: implications for neurodegeneration. <em>Journal of neuroinflammation</em>. https://doi.org/10.1186/s12974-025-03664-4
Vancouver
HJ K, JH A, MH W, DW. K. Chronic periodontitis and systemic inflammation in the elderly: implications for neurodegeneration. Journal of neuroinflammation. 2026. doi:10.1186/s12974-025-03664-4.
BibTeX
@article{kwon2026Chroni,
title = {Chronic periodontitis and systemic inflammation in the elderly: implications for neurodegeneration.},
author = {Kwon HJ and Ahn JH and Won MH and Kim DW.},
journal = {Journal of neuroinflammation},
year = {2026},
doi = {10.1186/s12974-025-03664-4},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of oral microbiology 2025
Open access · OA
The oral microbiome in aging: a window into health and longevity.
Nutrients 2026
Open access · CC-BY
Dietary Polyphenols in Brain Aging: Molecular Mechanisms and Implications for Neurodegeneration
Frontiers in Immunology 2022
Open access · CC-BY
Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging
Ageing Research Reviews 2026
Open access · CC-BY
Influenza vaccination as a modulator of inflammaging: Trained tolerance as a mechanistic lens on heterologous effects in age-related diseases
Ageing research reviews 2026
Citation only
Influenza vaccination as a modulator of inflammaging: Trained tolerance as a mechanistic lens on heterologous effects in age-related diseases.
Frontiers in Immunology 2026
Open access · CC-BY